Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|April 21, 2011
Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDLAndreas K Kateifides, Irina N Gorshkova, Adelina Duka, et al.
Metabolism: Clinical and Experimental|December 8, 2020
Advances in biological therapies for dyslipidemias and atherosclerosisEftaxia-Konstantina Valanti, Katerina Dalakoura-Karagkouni, Gerasimos Siasos, et al.
Journal of Cellular Physiology|April 25, 2019
Significant changes in hepatic transcriptome and circulating miRNAs are associated with diet-induced metabolic syndrome in apoE3L.CETP miceDimitris Nasias, Ioannis Evangelakos, Vasilis Nidris, et al.
Biochemical and Biophysical Research Communications|November 1, 2015
Thyroid hormones upregulate apolipoprotein E gene expression in astrocytesCorina Roman, Elena V Fuior, Violeta G Trusca, et al.
Handbook of Experimental Pharmacology|December 20, 2014
HDL biogenesis, remodeling, and catabolismVassilis I Zannis, Panagiotis Fotakis, Georgios Koukos, et al.
Cell Death and Differentiation|December 13, 2017
Snail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinomaClaudia Bellomo, Laia Caja, Isabel Fabregat, et al.
The Journal of Biological Chemistry|June 8, 2007
Inflammatory signaling pathways regulating ApoE gene expression in macrophagesAnca V Gafencu, Marius R Robciuc, Elena Fuior, et al.
Oncogenesis|May 18, 2019
LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiationAnita Morén, Claudia Bellomo, Yutaro Tsubakihara, et al.
Molecular Biology Reports|March 6, 2026
HepG2 cells stimulated by THP-1-conditioned medium: a potential in vitro model of systemic inflammation-induced hepatic alterationsVeronika Vyletelová, Marek Bohunčák, Jana Hricovíniová, et al.
Journal of the American Heart Association|May 28, 2024
Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human CD39L3 Apyrase) Alone and in Combination With Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo-Controlled StudyDimitris Kardassis, Ann-Charlotte Egnell, Magnus Åstrand, et al.
Pageof 10